Susulic VS, Frederich RC, Lawitts J, Tozzo E, Kahn BB, Harper ME, Himms-Hagen J, Flier JS, Lowell BB
Comprehensive analysis of -catenin target genes in colorectal carcinoma cell lines with deregulated Wnt/-catenin signaling
Key Reasons for the Ban: Lack of scientific and therapeutic rationale for combination use No added clinical benefit over individual drug therapy Increased risk of adverse drug reactions and drug interactions Potential contribution to antimicrobial resistance (in antibiotic combinations) Overall unnecessary burden on patients and healthcare systems Regulatory Action: The ban reflects Indias strengthened approach toward evidence-based medicine and rational drug use, ensuring that only safe, effective, and clinically justified drug combinations remain in the market
These levels can also fluctuate daily, so assessing the nutrient impact on cellular function is best to understand long-term nutritional status better
That said, there are clinical trends: The prescribing information for Ozempic mentions alopecia, or hair loss, as a documented side effect
Do they have the license